LSI Mission
To improve human health through collaborative scientific discovery.
|
See something here that you'd like to pass along to a friend?
Click 'forward e-mail' at the bottom of the newsletter.
|
|
LSI's Innovation Partnership Accelerates Progress in First Four Projects

The
Innovation Partnership at the Life Sciences Institute marked its first year
with one project spinning off into a new company focusing on obesity and diabetes
treatment and the other three drug discovery projects making accelerated
progress towards treatments in the areas of
neurodegenerative disease, bacterial infection, and cancer. The first-year results are detailed in a report just issued by the LSI.
Project Focus: Untangling Alzheimer's
5.3 million people have Alzheimer's disease, which is caused by abnormal protein misfolding and accumulation that leads to the formation of a neurotoxic tangled structure in the brain that kills neurons for good. The lab of LSI faculty member Jason Gestwicki, PhD was interested in answering the question: What prevents this from happening in everyone? Is there a "protein quality control" process in the brain that prevents the accumulation of these toxic proteins? How does it work?The team searched for small molecules that stimulate the activity of a protein called Hsp70, which prevents the protein misfolding in brain cells that causes progressive neurological diseases like Alzheimer's. After screening tens of thousands of potential compounds in the LSI's Center for Chemical Genomics (CCG), the Gestwicki team identified two particularly interesting chemicals and figured out how they bind to and regulate Hsp70.Read the full story
|
Tesmer Lab Publishes Latest Findings: Reveals first complete cystal structure of a G protein-coupled receptor kinase
G protein-coupled receptors (GPCRs) constitute a
large protein family of receptors that are able to sense molecules outside of
the cell, such as light, odorants, and hormones. These extracellular cues then
trigger a cascade of events that leads to physiological changes in the cell.
However, these activated receptors are soon "turned off" in order to allow
cells to adapt to changes in their environment and avoid oxidative damage.

This
process, called desensitization, is initiated by a family of proteins known as
GPCR kinases (GRKs). Defects in desensitization are known to cause night
blindness, and abnormally elevated GRK activity is believed to play a role in
heart failure and addiction. Previously, scientists suspected that GRKs have a "receptor docking
site" responsible for recognition of activated GPCRs, but the molecular
architecture of this docking site and how it serves as a trigger for activation
of kinase activity was not known. In a paper recently published in The EMBO
Journal, Life Sciences Institute Research Associate Professor John Tesmer
and colleagues describe the crystal structure of GRK6 in a novel, closed
conformation, in which all the regions known to be critical for receptor
phosphorylation (the addition of a phosphate group to a protein group) are
ordered and have coalesced to form a likely docking site for activated receptors.
This is the most complete GRK structure determined to date.
Read the full story
|
Part Two: Read David Sherman's Dive Journal Peek into the pages of his Costa Rica expedition notes
David Sherman back in the lab with hundreds of new hand-picked samples  |
LSI scientist and explorer David Sherman recently returned from an expedition to Costa Rica in support of his multi-year drug discovery and bioenergy project.
Though he faced underwater waves, epic rains, and a multitude of unusual creatures on land and in the sea, he and his team made it back to Ann Arbor safely and back into the lab with hundreds of new samples hand-plucked from the sea floor and decaying jungle logs.
Read part two of his story and see photos from his dives and sample collection in the remote seas and jungles of Costa Rica
|
The Latest on the LSI Website Check out the latest news and research
|
About University of Michigan Life Sciences Institute
At the
University of Michigan Life Sciences Institute (LSI) a team of more than 400 professionals-including
world-class faculty and researchers in chemistry, cell and developmental
biology, physiology, human genetics, bioinformatics, hematology and oncology
works together to solve fundamental problems in human health. Founded in 2002,
the LSI serves as an intellectual and biomedical technology hub for the entire
University of Michigan system.
University of Michigan Life Sciences Institute 210 Washtenaw Ann Arbor, Michigan 48109
|
|